Zobrazeno 1 - 10
of 72
pro vyhledávání: '"E. Giangreco"'
Autor:
F.S. Macaluso, M. Grova, F. Mocciaro, R. Di Mitri, A. Privitera, M. Distefano, A. Vitello, S. Camilleri, C. Ferracane, D. Pluchino, N. Belluardo, E. Giangreco, W. Fries, A. Viola, M. Cappello, L. D'Amato, C. Bertolami, M. Ventimiglia, S. Renna, A. Casa, S. De Vivo, A. Orlando
Publikováno v:
Digestive and Liver Disease. 55:S159-S160
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf31c5d6112517d4993928d495d04ebe
https://doi.org/10.1016/s1590-8658(23)00390-0
https://doi.org/10.1016/s1590-8658(23)00390-0
Autor:
F.S. Macaluso, E. D'Antonio, W. Fries, A. Viola, O. Ksissa, M. Cappello, S. Muscarella, N. Belluardo, E. Giangreco, F. Mocciaro, R. Di Mitri, C. Ferracane, A. Vitello, M. Grova, S. Renna, A. Casa, M. Ventimiglia, A. Orlando
Publikováno v:
Digestive and Liver Disease. 55:S178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ea506805c842bedc21bec0d5dff1036
https://doi.org/10.1016/s1590-8658(23)00429-2
https://doi.org/10.1016/s1590-8658(23)00429-2
Autor:
A. Trovatello, Giulia Rizzuto, Marco Ventimiglia, E. Giangreco, Andrea Centritto, R. Orlando, Fabio Salvatore Macaluso, Giovita Piccillo, Maria Cappello, E. Giuffrida, C. Bertolami, Walter Fries, R. Vassallo, S. Camilleri, A. Magnano, Sara Renna, Ambrogio Orlando, Anna Viola, Antonino Carlo Privitera, N. Belluardo, Elisa Vinci, S. Garufi
Publikováno v:
Inflammatory Bowel Diseases. 27:182-189
Background No data on the recently introduced infliximab (IFX) biosimilar SB2 in inflammatory bowel disease (IBD) are available. Methods The Sicilian Prospective Observational Study of Patients With IBD Treated With Infliximab Biosimilar SB2 is a mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109a32cabf881d905239a1e1a3212c55
https://doi.org/10.1093/ibd/izaa036
https://doi.org/10.1093/ibd/izaa036
Autor:
F.S. Macaluso, M. Grova, M. Saladino, M.G. Demarzo, A.C. Privitera, E. Giangreco, S. Garufi, S. Renna, A. Casà, M. Ventimiglia, M. Cappello, W. Fries, A. Orlando
Publikováno v:
Digestive and Liver Disease. 54:S93-S94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f36ee073856fa86b3eb84e8e275eb5af
https://doi.org/10.1016/s1590-8658(22)00328-0
https://doi.org/10.1016/s1590-8658(22)00328-0
Autor:
F S Macaluso, M Grova, M Saladino, M G Demarzo, A C Privitera, E Giangreco, S Garufi, S Renna, A Casà, M Ventimiglia, M Cappello, W Fries, A Orlando
Publikováno v:
Journal of Crohn's and Colitis. 16:i359-i360
Background There is no head-to-head trial comparing ustekinumab (UST) and vedolizumab (VDZ) in Crohn’s disease (CD). Recently, real-world studies evaluated the two biologics in patients refractory to anti-TNF therapy, i.e. as second-line agents. Co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1c2ed974351ecf266b1045011b33f5b
https://doi.org/10.1093/ecco-jcc/jjab232.472
https://doi.org/10.1093/ecco-jcc/jjab232.472
Autor:
Fabio Salvatore Macaluso, A. Magnano, Sara Renna, Marco Ventimiglia, Ambrogio Orlando, Elisa Vinci, C. Ferracane, Giulia Rizzuto, B. Scrivo, Giovita Piccillo, Francesco Graziano, Claudio Romano, A. Casà, S. Garufi, Walter Fries, C. Bertolami, Maria Cappello, Anna Viola, Giuseppe Costantino, Giulia Teresi, Antonino Carlo Privitera, N. Belluardo, E. Giangreco, Michele Citrano, A. Busacca
Publikováno v:
Journal of gastroenterology and hepatologyReferences. 36(11)
BACKGROUND AND AIM There are few clinical data on Adalimumab (ADA) biosimilars in inflammatory bowel disease. We aimed to perform a multicenter, observational, prospective study on safety and effectiveness of ADA biosimilar ABP 501 in patients with i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f0ad369d94144ec00ae9b0bd49ea090
https://pubmed.ncbi.nlm.nih.gov/34152636
https://pubmed.ncbi.nlm.nih.gov/34152636
Autor:
A.C. Privitera, Maria Cappello, Giuseppe Costantino, Giulia Rizzuto, Corrado Romano, E. Vinci, S. Garufi, A. Magnano, N. Belluardo, Sara Renna, Michele Citrano, Anna Viola, Walter Fries, E. Giangreco, A. Busacca, A. Casà, C. Bertolami, Marco Ventimiglia, G. Piccillo, A. Orlando, C. Ferracane, F. Graziano, Fabio Salvatore Macaluso, B. Scrivo
Publikováno v:
Digestive and Liver Disease. 53:S162-S163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3480bcc2239d6b18604d8c8c148d327
https://doi.org/10.1016/s1590-8658(21)00620-4
https://doi.org/10.1016/s1590-8658(21)00620-4
Autor:
Marcello Maida, A. Casà, Walter Fries, Anna Viola, S. Camilleri, Maria Cappello, N. Belluardo, R. Di Mitri, Mauro Grova, A. Magnano, F. Mocciaro, A. Orlando, A.C. Privitera, E. Giangreco, C. Ferracane, Sara Renna, G. Piccillo, S. Garufi, Federica Crispino, Fabio Salvatore Macaluso
Publikováno v:
Digestive and Liver Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::615948fc892d3b8dcce49ed861538d7f
https://doi.org/10.1016/s1590-8658(21)00614-9
https://doi.org/10.1016/s1590-8658(21)00614-9
Publikováno v:
2020 5th International Conference on Smart and Sustainable Technologies (SpliTech).
The modern age of Big Data, mostly leveraged by the consolidation of the IoT paradigm, leads to the need of giving meaning to the great amount of data, especially within the smart city. It is fundamental to extract value from the information we all a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1430791b822d8d397347308da5e4b6f
https://doi.org/10.23919/splitech49282.2020.9243831
https://doi.org/10.23919/splitech49282.2020.9243831
Autor:
Maria Cappello, S. Garufi, Mario Cottone, S. Camilleri, Roberto Di Mitri, Antonino Carlo Privitera, A Sitibondo, B. Scrivo, Fabio Salvatore Macaluso, N. Belluardo, R. Orlando, Anna Viola, Walter Fries, E. Giangreco, C. Bertolami, A. Busacca, Sara Renna, Ambrogio Orlando, Marco Ventimiglia, Filippo Mocciaro, Giulia Rizzuto
Publikováno v:
Journal of gastroenterology and hepatologyReferences. 36(1)
Background and aim There are no head-to-head randomized controlled trials between biologics in Crohn's disease (CD). We aimed to perform a multicenter, real-life comparison of the effectiveness of vedolizumab (VDZ) and adalimumab (ADA) in CD. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e09dc8f92c3256cc09e593216857a734
https://pubmed.ncbi.nlm.nih.gov/32428981
https://pubmed.ncbi.nlm.nih.gov/32428981